Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer
Clinical trial NCT03982485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03982485
- Sponsor
- RenJi Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2023-03-29
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.